During the past decade, Raymond G. Murphy VA Medical Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Raymond G. Murphy VA Medical Center" #1 sponsor was "Hoffmann-La Roche" with 1 trials, followed by "Janssen Vaccines & Prevention B.V." with 1 trials sponsored, "Kowa Research Institute, Inc." with 1 trials sponsored, "Suzhou Kintor Pharmaceutical Inc," with 1 trials sponsored and "University of New Mexico" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Raymond G. Murphy VA Medical Center" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Raymond G. Murphy VA Medical Center" are "Chronic Pain" (1 trials), "Covid19" (1 trials), "Dyslipidemia" (1 trials), "Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol" (1 trials) and "Problematic Opioid Use" (1 trials). Many other conditions were trialed in "Raymond G. Murphy VA Medical Center" in a lesser frequency.

Most popular intervention types in "Raymond G. Murphy VA Medical Center" are "Drug" (3 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Acceptance and Commitment Therapy + Mindfulness-Based Relapse Prevention + Treatment as Usual (TAU)" (1 trials), "Ad26.COV2.S" (1 trials), "Antipshychotics (Standard of Care)" (1 trials) and "GT0918" (1 trials). Other intervention names were less common.

The vast majority of trials in "Raymond G. Murphy VA Medical Center" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Raymond G. Murphy VA Medical Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Raymond G. Murphy VA Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Raymond G. Murphy VA Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".